Previous slide
Next slide
About High Heights Biotech

At High Heights Biotech, we are committed to bridging the gap between biotech innovations and business, making them accessible globally to those who need it most.

Skills

About Helio Liver

We are proud to announce that High Heights Biotech has been appointed as the official business development partner for the international launch of HelioLiver™ early detection cancer testing by Helio Genomics. With a shared commitment to improving healthcare outcomes, we are dedicated to expanding access to this ground-breaking technology and fostering collaborative partnerships to introduce HelioLiver™ to healthcare providers and patients worldwide.

A New Solution for Early Cancer Detection

The HelioLiver test delivers superior performance characteristics when compared to traditional blood tests for hepatocellular carcinoma.

HELIOLIVER 91% Specificity AFP GALAD
Early Stage Sensitivity 76% 57% 65%
Overall Sensitivity 85% 62% 75%

Empowering Biotech Innovators
on the Global Stage​

Introducing the HelioLiver™ Test

HelioLiver™ is a revolutionary multi-analyte blood test that reimagines how we find and fight liver cancer by simplifying screening for patients.

HelioLiver™ requires only a simple blood draw that offers at-risk patients an easy way to detect early liver cancer allowing for more time to treat the disease and for significantly improve outcomes.

HelioLiver™ represents a breakthrough in early detection, leveraging state-of-the-art technology to analyse circulating protein tumour markers and cell-free DNA (cfDNA) methylation testing to identify hepatocellular carcinoma (HCC) with unprecedented accuracy.

If you’re ready to take your biotech business to new heights and expand your global reach, look no further than High Heights Biotech. Contact us today to schedule a consultation and let us help you unlock the potential of international marketing in the world of medical device biotechnology. Together, we can make a difference.


Bridge the Gap between innovation and business, with High Heights Biotech

Working With You To Bridge The Gap

OUR SERVICES

Tailored Go-To-Market Solutions

At High Heights Biotech, we recognize that the success of your biotechnology lies not only in its scientific breakthrough but also in its ability to reach the right audience. With our extensive network and global reach, we have the power to introduce your groundbreaking innovations to key stakeholders, investors, networks, and customers worldwide

Tailored Commercial Strategy

Our approach is rooted in meticulous market research and analysis. We dig deep to understand the unique challenges and opportunities in your industry, identify emerging trends, and uncover untapped market segments. Armed with this knowledge, we develop data-driven strategies that position your biotech innovation for maximum impact and market penetration

Tailored Business Partner Vetting

Business partner vetting is crucial for ensuring that you choose the right individuals or entities when entering into partnerships. At High Heights Biotech we conduct an in-depth assessment of your business goals, objectives, and areas where you require support or expertise, and identify potential partners with the key criteria required such as industry experience, technical skills, market knowledge, geographic reach, financial stability, and cultural fit.

Tailored On-Going Management

Once commercialised, our service doesn’t stop there. At High Heights Biotech we can provide tailored ongoing management solutions to drive sustainable growth and profitability over the long term. This may involve continuous monitoring and analysis of business performance, commercial objectives, market trends, customer preferences & feedback, opportunities & threats, competitor actions, and regulatory changes.

Contact

Contact Us

    Improved Patient Outcomes

    Remove barriers to routine screening with expanded availability and convenience

    High Sensitivity

    Our test is more sensitive than currently available blood based tests for the early detection of HCC

    Reliability

    Get simple, easy-to-interpret results that are immediately actionable for providers and patients

    Outcomes

    Remove barriers to routine screening with expanded availability and convenience

    George Panagios

    Tertiary Science & Business qualifications. Over 30 years of international experience in Sales, Marketing and Executive roles in multinational Pharmaceutical, Chemical, Genetics, Medical Diagnostics & Nutraceutical industries, including Go-To-Market product implementation and commercial business start-ups.

    John Kilborn

    Tertiary Science & Business qualifications. Over 30 years of international experience in Sales, Marketing and Executive roles in multinational Pharmaceutical, Medical Diagnostics & Nutraceutical industries, as well as senior positions on various pharmaceutical & government advisory boards. Experience in founding, funding, and growing multiple start-ups in the science and nutritional space.

    Dr Oojin Choy

    Dr. Oojin Choy, is a physician and surgeon in the San Francisco Bay Area over the past 30 years. Dr. Choy’s trained UC Davis General Surgery program. Driven by a passion for advancing medical knowledge, Dr. Choy embarked on cardiac research at Lawrence Livermore Laboratory in Berkeley. Through his research efforts, he contributed to the field of cardiac surgery. Building upon his extensive knowledge and research experience, Dr. Choy pursued a fellowship in Thoracic Surgery at UC San Francisco. This highly specialized training equipped him with the advanced surgical techniques and in-depth understanding required to address complex thoracic conditions, including diseases of the lungs, esophagus, and chest wall.

    Dr Oojin Choy

    Dr. Oojin Choy, is a physician and surgeon in the San Francisco Bay Area over the past 30 years. Dr. Choy’s trained UC Davis General Surgery program. Driven by a passion for advancing medical knowledge, Dr. Choy embarked on cardiac research at Lawrence Livermore Laboratory in Berkeley. Through his research efforts, he contributed to the field of cardiac surgery. Building upon his extensive knowledge and research experience, Dr. Choy pursued a fellowship in Thoracic Surgery at UC San Francisco. This highly specialized training equipped him with the advanced surgical techniques and in-depth understanding required to address complex thoracic conditions, including diseases of the lungs, esophagus, and chest wall.

    Dr Susan Lin

    Susan Lin, MD, is a medical professional for over 30 years a diverse background in education, board appointments, published research and business. She graduated from Boston University School Six Year Medical Program with NIH Cancer Research Fellowship. Dr. Lin completed postdoctoral training in Obstetrics and Gynecology at Kaiser Permanente Oakland, Felix Rutledge Oncology Fellowship at MD Anderson Cancer Center, Galloway Fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Lin has held various esteemed positions within the medical community.

    Since 2004, she has served as an Expert Reviewer for the Medical Board of California, contributing her valuable insights and expertise to the regulatory processes. Dr. Lin was a member of American College of Obstetrics and Gynecology, the American Academy of Antiaging Medicine, the American Academy of Aesthetic Medicine, and the American Society for Laser Medicine and Surgery.

    Pranshu Batta

    Business qualifications. 4Th generation of domestic and international experience in large-scale business development and investment, harnessing the power of global networks and relationships.